Current and future trends in clostridioides (clostridium) difficile infection management
Authors:
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled TrialsClinical Infectious Diseases, 2014
- Multistate Point-Prevalence Survey of Health Care–Associated InfectionsNew England Journal of Medicine, 2014
- Duodenal Infusion of Donor Feces for RecurrentClostridium difficileNew England Journal of Medicine, 2013
- Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trialThe Lancet Infectious Diseases, 2012
- Host and Pathogen Factors forClostridium difficileInfection and ColonizationNew England Journal of Medicine, 2011
- Fidaxomicin versus Vancomycin forClostridium difficileInfectionNew England Journal of Medicine, 2011
- Health Care–AssociatedClostridium difficileInfection in Adults Admitted to Acute Care Hospitals in Canada: A Canadian Nosocomial Infection Surveillance Program StudyClinical Infectious Diseases, 2009
- PROSPECTIVE RANDOMISED TRIAL OF METRONIDAZOLE VERSUS VANCOMYCIN FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHOEA AND COLITISThe Lancet, 1983
- ORAL VANCOMYCIN FOR ANTIBIOTIC-ASSOCIATED PSEUDOMEMBRANOUS COLITISThe Lancet, 1978
- Clindamycin-Associated ColitisAnnals of Internal Medicine, 1974